Patients with a highly significant increase in CD4 + , but not CD8 + , TCR diversity after 6 weeks of PD-1 inhibition were more likely to achieve a CR.
← all excerpts
The Evolving Knowledge on T and NK Cells in Classic Hodgkin Lymphoma: Insights into Novel Subsets Populating the Immune Microenvironment.
1
—
—